Outsourcing-Pharma
1,738 FOLLOWERS
In-PharmaTechnologist.com is a daily news service that provides news stories and data of value to decision-makers in the Pharmaceutical Technology industry.
Outsourcing-Pharma
2M ago
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025 ..read more
Outsourcing-Pharma
2M ago
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a PET imaging agent for neuroendocrine tumors, pending FDA approval ..read more
Outsourcing-Pharma
2M ago
Throughout her career, One2Treat’s Émilie Barré has focused on developing both the analytical and leadership aspects necessary for success in the field ..read more
Outsourcing-Pharma
2M ago
Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases ..read more
Outsourcing-Pharma
2M ago
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are planned ..read more
Outsourcing-Pharma
2M ago
Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for rare diseases and skin conditions, including Alzheimer's and acne vulgaris ..read more
Outsourcing-Pharma
2M ago
From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024 ..read more
Outsourcing-Pharma
3M ago
Australian CDMOs, BioCina and NovaCina, have merged in a move to pool their biologic and small molecule production expertise and infrastructure ..read more
Outsourcing-Pharma
3M ago
Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight loss effects the drug is known for ..read more
Outsourcing-Pharma
3M ago
We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient centricity in terms of clinical trials and how the industry can navigate the evolving regulatory expectations around it ..read more